SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.13-0.5%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (6623)7/4/1998 10:16:00 PM
From: William L. Molair II  Read Replies (2) of 17367
 
Murphmeister spoke with Xoma last week. In the latest CTSL he lists the following target dates :

September - Safety Review
December - Phase III trial ends
March 99 - 90 Day followups complete & unblind data
June 99 - New Drug Application

Xoma was also missing from the Best New Trades list. It was on the Best New Trades list last issue for the first time in a long time.

My thoughts/interpretation is that he thinks the stock will not move higher until much later this year based on the above schedule. CTSL did not perform very well last year and he seems to be focussing on stocks that will have news in the short term vs. a stock that should have good news (we hope) next year. My only wish is that he was taking this approach in Feb 1997 when he began heavily hyping XOMA stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext